NAR Cancer article, with contributions from Wendell Jones, PhD, Q2 Solutions GenomicsUterine serous carcinoma (USC), an aggressive variant of endometrial cancer representing approximately 10% of...
With a renewed interest in vaccine research and development (R&D), stakeholders across the industry are rethinking their approach to the field. Biopharmaceutical companies have growing numbers of...
Stakeholders from across the industry, including biopharmaceutical companies, governments, and non-profit organizations, are rethinking their pandemic readiness in light of the COVID-19 pandemic,...
With state-of-the-art laboratory testing services, next-generation technology, and agile solutions tailored to meet the diverse needs of our clientele around the world, it's no coincidence that Life...
Clinical trials can be envisioned as an ecosystem of laboratories, vendors, and biobanks knitted together by patient samples and data. Tracking patient samples and consent across this highly complex...